Avenue Therapeutics (ATXI) Stock Chart & Stock Price History $0.22 -0.05 (-18.43%) As of 06/11/2025 02:40 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Avenue Therapeutics Stock Price Performance The Avenue Therapeutics (ATXI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 93.82%, with a year-to-date return of -89.23%. In the past month, the stock has decreased 8.30%, reflecting recent market activity. As of the latest close, Avenue Therapeutics traded at $0.22 with a market cap of $686 thousand and volume of 4,115 shares. Five years ago, the stock traded at a split-adjusted price of $11,587.50, representing a 100.00% decrease over that period. At the time, it had a market cap of $178.34 million and a volume of 629 shares. Receive ATXI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-17.12%1 Month Performance-8.30%3 Month Performance-77.21%Year-To-Date Performance-89.23%1 Year Performance-93.82%5 Year Performance-100.00% ATXI Stock Chart for Thursday, June, 12, 2025 ATXI Chart by TradingView Avenue Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$0.26$0.22-17.12%$0.26$0.224,115 shs$686,000.0006/10/2025$0.20$0.26+29.55%$0.26$0.203,676 shs$828,000.0006/09/2025$0.26$0.20-22.81%$0.26$0.2011,327 shs$639,000.0006/06/2025$0.25$0.26+4.00%$0.26$0.20899 shs$828,000.0006/05/2025$0.26$0.25-3.85%$0.25$0.25234 shs$796,000.0006/04/2025$0.26$0.26$0.26$0.26219 shs$828,000.0006/03/2025$0.25$0.26+4.00%$0.26$0.202,006 shs$828,000.0006/02/2025$0.22$0.25+14.73%$0.25$0.201,245 shs$796,000.0005/30/2025$0.24$0.22-9.96%$0.22$0.221,126 shs$694,000.0005/29/2025$0.26$0.24-6.89%$0.26$0.2013,694 shs$770,000.00 Get the Latest News and Ratings for ATXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$0.25$0.26+4.04%$0.26$0.173,192 shs$827,000.0005/27/2025$0.21$0.25+19.64%$0.25$0.201,193 shs$795,000.0005/26/2025$0.21$0.21$0.23$0.213,324 shs$665,000.0005/23/2025$0.22$0.21-5.13%$0.23$0.213,324 shs$665,000.0005/22/2025$0.22$0.22$0.22$0.22736 shs$701,000.0005/21/2025$0.22$0.22$0.22$0.22736 shs$701,000.0005/20/2025$0.22$0.22$0.22$0.22362 shs$701,000.0005/19/2025$0.22$0.22$0.25$0.222,522 shs$701,000.0005/16/2025$0.25$0.22-11.96%$0.22$0.22629 shs$701,000.0005/15/2025$0.24$0.25+4.17%$0.25$0.239,829 shs$796,000.0005/14/2025$0.18$0.24+36.99%$0.25$0.181,113 shs$764,000.0005/13/2025$0.24$0.18-25.45%$0.18$0.172,753 shs$558,000.0005/12/2025$0.24$0.24-2.08%$0.25$0.231,077 shs$748,000.00 Related Companies Windtree Therapeutics Stock Price Chart GRI Bio Stock Price Chart Jaguar Health Stock Price Chart Spruce Biosciences Stock Price Chart Psyence Biomedical Stock Price Chart Scinai Immunotherapeutics Stock Price Chart Palatin Technologies Stock Price Chart Aspira Women's Health Stock Price Chart TNF Pharmaceuticals Stock Price Chart Galmed Pharmaceuticals Stock Price Chart Receive ATXI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATXI) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avenue Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avenue Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
